Pacific Securities Co., Ltd.
Audit Opinion on Tianjin Jiuan Medical Electronic Co., Ltd.'s 2025 Raised Funds Storage and Usage
In accordance with the "Administrative Measures for Securities Issuance and Listing Sponsorship Business," "Guiding Opinions of the China Securities Regulatory Commission on the Supervision of Listed Companies' Raised Funds Management and Use," "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 1 - Standardized Operation of Main Board Listed Companies," and "Shenzhen Stock Exchange Listed Company Self-Regulatory Guidelines No. 13 - Sponsorship Business," Pacific Securities Co., Ltd. (hereinafter referred to as "Pacific Securities" or "Sponsor"), as the continuous sponsor for Tianjin Jiuan Medical Electronic Co., Ltd. (hereinafter referred to as "Jiuan Medical," "Company," or "Issuer") for its 2020 private placement, has audited the Company's 2025 raised funds storage and usage. The audit findings and opinions are as follows:
I. Basic Situation of Raised Funds
(I) Actual Amount of Raised Funds and Time of Receipt
As approved by the China Securities Regulatory Commission's (hereinafter referred to as "CSRC") "Approval for Tianjin Jiuan Medical Electronic Co., Ltd.'s Private Placement of Shares" (Zheng Jian Xu Ke [2020] No. 3324), the Company issued 45,797,101 shares of RMB ordinary shares (A shares) through a private placement in 2020, with a par value of RMB 1.00 per share and an issue price of RMB 6.90 per share. The total raised funds amounted to RMB 315,999,996.90. After deducting issuance-related expenses of RMB 6,630,702.76, the net amount of raised funds was RMB 309,369,294.14.